Jane Street
ATHE

Jane Street’s Alterity Therapeutics ATHE Stock Holding History

Jane Street’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,561
Closed -$200K – 2456
2014
Q3 		$200K Sell
1,561
-583
-27% -$78K ﹤0.01% 2228
2014
Q2 		$291K Buy
2,144
+1,083
+102% +$123K ﹤0.01% 1864
2014
Q1 		$178K Sell
1,061
-762
-42% -$421K ﹤0.01% 2401
2013
Q4 		$767K Buy
1,823
+1,268
+228% +$379K 0.01% 933
2013
Q3 		$137K Buy
+555
New +$127K ﹤0.01% 2499

Other funds holding ATHE

VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CAM
Columbia Asset Management Ann Arbor, Michigan $575M AUM 29.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Jane Street's ATHE Position: Q4 2014 in Review

Jane Street sold out of Alterity Therapeutics (ATHE) in Q4 2014, closing a stake of 1,561 shares — an estimated $200K sold.

Jane Street first reported a position in ATHE in Q3 2013 and held it in 5 quarters. The position peaked at $767K in Q4 2013. 24 funds tracked by Wall St. Rank hold ATHE as of Q4 2014.

  • Jane Street reported no remaining Alterity Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Jane Street sold 1,561 Alterity Therapeutics shares in Q4 2014, an estimated $200K.
  • Jane Street first reported a position in Alterity Therapeutics in Q3 2013 and held it in 5 quarters.
  • Jane Street's Alterity Therapeutics position peaked at $767K in Q4 2013.
  • 24 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q4 2014.

Based on Jane Street's 13F filing for Q4 2014, filed 17 Feb 2015.